Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorine Bellanger

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Pathology|July 5, 2021
Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissueAlix Fontaine, Dorine Bellanger, Roseline Guibon, et al.
Cancers|August 7, 2021
Adipocytes Promote Breast Cancer Cell Survival and Migration through Autophagy ActivationDorine Bellanger, Cléa Dziagwa, Cyrille Guimaraes, et al.
The Prostate|December 19, 2023
Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factorsMathilde Cancel, David Crottes, Dorine Bellanger, et al.
Computational and Structural Biotechnology Journal|March 29, 2021
Functional and conformational impact of cancer-associated <i>SF3B1</i> mutations depends on the position and the charge of amino acid substitutionChristine Canbezdi, Malcy Tarin, Alexandre Houy, et al.
European Journal of Human Genetics : EJHG|November 11, 2011
Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutationsVirginie Jacquemin, Guillaume Rieunier, Sandrine Jacob, et al.
Blood|December 13, 2007
Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemiaEmilie Le Toriellec, Gilles Despouy, Gaëlle Pierron, et al.
Nature Communications|October 13, 2015
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasTina Gruosso, Camille Garnier, Sophie Abelanet, et al.
Cell Communication and Signaling : CCS|October 2, 2025
Investigation of the heterogeneity of cancer cells using single cell Ca<sup>2+</sup> profilingAmélie E Bura, Camille Caussette, Maxime Guéguinou, et al.
Oncogene|October 15, 2020
Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancersSamar Alsafadi, Stephane Dayot, Malcy Tarin, et al.
Oncotarget|October 27, 2017
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial functionLucie Hebert, Dorine Bellanger, Chloé Guillas, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Pathology|July 5, 2021
Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissueAlix Fontaine, Dorine Bellanger, Roseline Guibon, et al.
Cancers|August 7, 2021
Adipocytes Promote Breast Cancer Cell Survival and Migration through Autophagy ActivationDorine Bellanger, Cléa Dziagwa, Cyrille Guimaraes, et al.
The Prostate|December 19, 2023
Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factorsMathilde Cancel, David Crottes, Dorine Bellanger, et al.
Computational and Structural Biotechnology Journal|March 29, 2021
Functional and conformational impact of cancer-associated <i>SF3B1</i> mutations depends on the position and the charge of amino acid substitutionChristine Canbezdi, Malcy Tarin, Alexandre Houy, et al.
European Journal of Human Genetics : EJHG|November 11, 2011
Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutationsVirginie Jacquemin, Guillaume Rieunier, Sandrine Jacob, et al.
Blood|December 13, 2007
Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemiaEmilie Le Toriellec, Gilles Despouy, Gaëlle Pierron, et al.
Nature Communications|October 13, 2015
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasTina Gruosso, Camille Garnier, Sophie Abelanet, et al.
Cell Communication and Signaling : CCS|October 2, 2025
Investigation of the heterogeneity of cancer cells using single cell Ca<sup>2+</sup> profilingAmélie E Bura, Camille Caussette, Maxime Guéguinou, et al.
Oncogene|October 15, 2020
Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancersSamar Alsafadi, Stephane Dayot, Malcy Tarin, et al.
Oncotarget|October 27, 2017
Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial functionLucie Hebert, Dorine Bellanger, Chloé Guillas, et al.
Pageof 2